You are viewing the "Brian Mann | NPR" Archives
WASHINGTON, D.C. (NPR) — Four of the largest U.S. corporations have agreed to pay roughly $26 billion to settle a tsunami of lawsuits linked to claims that their business practices helped fuel the deadly opioid crisis. Johnson & Johnson, the consumer products and health giant that manufactured generic opioid medications, will contribute $5 billion to… Read More
WASHINGTON, D.C. (NPR) — Over the next two weeks, some of the biggest U.S. corporations accused of “turbocharging” the opioid epidemic could finalize payouts to victims and governments worth roughly $32 billion. “We’ve lost more than a million Americans to this epidemic, and sadly, it’s at an all-time high as overdose deaths continue to rise,”… Read More
Under a chilly blue sky, a dozen men and women stood in a line on a devastated street in Dawson Springs, Ky., one of the small towns hit hardest by the swarm of tornadoes that raked the nation’s midsection Friday night into Saturday. Geoffrey Deibler, a police chief from neighboring Morganfield, came to volunteer on… Read More
CLEVELAND (NPR) — A federal jury on Tuesday found three of the nation’s biggest pharmacy chains, CVS, Walgreens and Walmart, liable for helping to fuel the U.S. opioid crisis. Jurors concluded that the pharmacies contributed to a so-called public nuisance in Lake and Trumbull counties in Ohio by selling and dispensing huge quantities of prescription… Read More
Updated October 14, 2021 at 8:43 AM NEW YORK (NPR) — In a surprise ruling late Wednesday a federal judge in New York allowed work to continue on implementation of a controversial bankruptcy plan for Purdue Pharma, the maker of Oxycontin. The U.S. Justice Department’s bankruptcy watchdog agency had urged Judge Colleen McMahon of the… Read More
Under a bankruptcy plan filed late Monday, the OxyContin maker would pay $500 million up front, promising billions in future payments. Twenty-four states rejected the proposal.
McKinsey is the latest major American corporation to face legal, financial and public relations peril stemming from its role in the nation’s deadly opioid epidemic.
Thousands of lawsuits that ground to a halt because of COVID-19 are moving forward again as local, state and federal courts reopen around the U.S.
If finalized, such a deal could funnel tens of billions of dollars to American communities struggling with the addiction crisis, while restoring stability to one of the country’s biggest industries.